DALLAS, Oct. 4, 2011 /PRNewswire/ -- Goldfarb Branham LLP is investigating whether the board of directors of Pharmaceutical Product Development (NASDAQ: PPDI) violated shareholder protection laws by agreeing to sell the company for $33.25 per share. Concerned investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com about their rights and remedies.
"As recently as mid-August, shares of the company were trading at $32.20 per share," securities lawyer Hamilton Lindley said. "Additionally, at least one analyst set a target price of $38.00 per share on the PPDI stock. Our proposed shareholder class action lawsuit seeks to ensure that investors get the most value for their stock in this buyout."
Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Pharmaceutical Product Development stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855.
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
|SOURCE Goldfarb Branham LLP|
Copyright©2010 PR Newswire.
All rights reserved